Literature DB >> 2496790

Increased risk of atherosclerosis in women after the menopause.

J C Witteman1, D E Grobbee, F J Kok, A Hofman, H A Valkenburg.   

Abstract

An increase in the incidence of cardiovascular disease has generally been observed in postmenopausal women, but there have been few studies of the association between menopausal state and atherosclerosis. In this study 294 premenopausal and 319 postmenopausal women aged 45 to 55 were examined radiographically for calcified deposits in the abdominal aorta, which have been shown to represent intimal atherosclerosis. Aortic atherosclerosis was present in eight (3%) of the premenopausal women and in 38 (12%) of the postmenopausal women. After adjustments for age and other indicators of cardiovascular risk women with a natural menopause had a 3.4 times greater risk of atherosclerosis than premenopausal women (95% confidence interval 1.2 to 9.7; p less than 0.05); women who had had a bilateral oophorectomy had a 5.5 times greater risk (1.9 to 15.8; p less than 0.005). No excess risk of atherosclerosis was observed among women who had had a hysterectomy without removal of both ovaries. These results suggest that when oestrogen production stops, either naturally or after surgery, the risk of atherosclerosis is increased.

Entities:  

Mesh:

Year:  1989        PMID: 2496790      PMCID: PMC1835855          DOI: 10.1136/bmj.298.6674.642

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  The incidence and severity of atherosclerosis in estrogen-treated males, and in females with a hypoestrogenic or a hyperestrogenic state.

Authors:  A U RIVIN; S P DIMITROFF
Journal:  Circulation       Date:  1954-04       Impact factor: 29.690

2.  The degree of coronary atherosclerosis in bilaterally oophorectomized women.

Authors:  J H WUEST; T J DRY; J E EDWARDS
Journal:  Circulation       Date:  1953-06       Impact factor: 29.690

3.  A study of the correlation between roentgenographic and post-mortem calcification of the aorta.

Authors:  J B HYMAN; F H EPSTEIN
Journal:  Am Heart J       Date:  1954-10       Impact factor: 4.749

4.  Relationship of calcified lesions to clinically significant atherosclerotic lesions.

Authors:  D A Eggen
Journal:  Ann N Y Acad Sci       Date:  1968-11-21       Impact factor: 5.691

5.  Menopausal change in serum cholesterol. Black/white differences in Evans County, Georgia.

Authors:  D D Baird; H A Tyroler; G Heiss; L E Chambless; C G Hames
Journal:  Am J Epidemiol       Date:  1985-12       Impact factor: 4.897

6.  [An epidemiological study of risk indicators for cardiovascular diseases (EPOZ). I. Blood pressure, serum cholesterol level, Quetelet-index and smoking habits in an open population aged 5 years and older].

Authors:  H A Valkenburg; A Hofman; F Klein; F N Groustra
Journal:  Ned Tijdschr Geneeskd       Date:  1980-02-09

7.  Menopause and risk of cardiovascular disease: the Framingham study.

Authors:  W B Kannel; M C Hjortland; P M McNamara; T Gordon
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391

8.  The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum.

Authors:  K Fischer-Dzoga; R W Wissler; D Vesselinovitch
Journal:  Exp Mol Pathol       Date:  1983-12       Impact factor: 3.362

9.  Aortic calcification as a predictor of cardiovascular mortality.

Authors:  J C Witteman; F J Kok; J L van Saase; H A Valkenburg
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

10.  Menopause and the risk of coronary heart disease in women.

Authors:  G A Colditz; W C Willett; M J Stampfer; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1987-04-30       Impact factor: 91.245

  10 in total
  48 in total

1.  Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women.

Authors:  R Y Man; L K Ting; S Fan; M M Lau; Y L Siow; Y H Chung; K O
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

Review 2.  The menopause and hormone replacement therapy.

Authors:  K T Khaw
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

Review 3.  Cardiovascular safety profiles of aromatase inhibitors : a comparative review.

Authors:  Jean-Marc Nabholtz; Joseph Gligorov
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.

Authors:  Adarsh J Sai; J Christopher Gallagher; Xiang Fang
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

Review 5.  Systemic hypertension in postmenopausal women: a clinical approach.

Authors:  Enrique Z Fisman; Alexander Tenenbaum; Amos Pines
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

6.  Increased risk of atherosclerosis in women after the menopause.

Authors:  C Bonithon-Kopp; P Y Scarabin; A Taquet; P J Touboul; B Damé; L Guize
Journal:  BMJ       Date:  1989-05-13

Review 7.  Hormone replacement treatment.

Authors:  P Belchetz
Journal:  BMJ       Date:  1989-06-03

8.  Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal women.

Authors:  Farzana Choudhury; Leslie Bernstein; Howard N Hodis; Frank Z Stanczyk; Wendy J Mack
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

9.  Vitamin D deficiency and degree of coronary artery luminal stenosis in women undergoing coronary angiography: a prospective observational study.

Authors:  Chris Morgan; Andreas Kyvernitakis; Roy Cho; Orestis Pappas; Karthikeyan Ranganathan; Michael R Fischer; Venkatraman Srinivasan
Journal:  Am J Cardiovasc Dis       Date:  2018-04-05

10.  Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.

Authors:  J Haarbo; P Leth-Espensen; S Stender; C Christiansen
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.